These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34948203)

  • 1. Plasma Lipid Profiling Contributes to Untangle the Complexity of Moyamoya Arteriopathy.
    Dei Cas M; Carrozzini T; Pollaci G; Potenza A; Nava S; Canavero I; Tinelli F; Gorla G; Vetrano IG; Acerbi F; Ferroli P; Ciceri EF; Esposito S; Saletti V; Ciusani E; Zulueta A; Paroni R; Parati EA; Ghidoni R; Bersano A; Gatti L
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells.
    Tinelli F; Nava S; Arioli F; Bedini G; Scelzo E; Lisini D; Faragò G; Gioppo A; Ciceri EF; Acerbi F; Ferroli P; Vetrano IG; Esposito S; Saletti V; Pantaleoni C; Zibordi F; Nardocci N; Zedde ML; Pezzini A; Di Lazzaro V; Capone F; Dell'Acqua ML; Vajkoczy P; Tournier-Lasserve E; Parati EA; Bersano A; Gatti L
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Circulating Factors in Moyamoya Disease.
    Fang YC; Wei LF; Hu CJ; Tu YK
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
    Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
    Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.
    Blecharz KG; Frey D; Schenkel T; Prinz V; Bedini G; Krug SM; Czabanka M; Wagner J; Fromm M; Bersano A; Vajkoczy P
    J Cereb Blood Flow Metab; 2017 Apr; 37(4):1527-1539. PubMed ID: 27381827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease.
    Bang OY; Chung JW; Kim SJ; Oh MJ; Kim SY; Cho YH; Cha J; Yeon JY; Kim KH; Kim GM; Chung CS; Lee KH; Ki CS; Jeon P; Kim JS; Hong SC; Moon GJ
    Int J Stroke; 2016 Dec; 11(9):999-1008. PubMed ID: 27462098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseases.
    Hu W; Jiang W; Ye L; Tian Y; Shen B; Wang K
    Sci Rep; 2017 Jul; 7(1):5452. PubMed ID: 28710384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy.
    Gorla G; Carrozzini T; Pollaci G; Potenza A; Nava S; Acerbi F; Ferroli P; Esposito S; Saletti V; Ciusani E; Zulueta A; Parati EA; Bersano A; Gatti L; Vetrano IG
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.
    Hojo M; Hoshimaru M; Miyamoto S; Taki W; Nagata I; Asahi M; Matsuura N; Ishizaki R; Kikuchi H; Hashimoto N
    J Neurosurg; 1998 Oct; 89(4):623-9. PubMed ID: 9761057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma fibronectin level in patients with moyamoya disease].
    Sasaki O; Tanaka R; Koike T; Takeuchi S; Takizawa T; Ishi R; Arai H
    No To Shinkei; 1987 Nov; 39(11):1069-73. PubMed ID: 3442638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
    Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
    Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease.
    Kang HS; Kim JH; Phi JH; Kim YY; Kim JE; Wang KC; Cho BK; Kim SK
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):673-8. PubMed ID: 19965844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Expression of Vascular Endothelial Growth Factor-A
    Jiang H; Toscano JF; Schiraldi M; Song SS; Schlick KH; Dumitrascu OM; Liou R; Lyden PD; Pan J; Zhan R; Saver JL; Gonzalez NR
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):360-368. PubMed ID: 30392834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
    Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
    Elife; 2020 Jun; 9():. PubMed ID: 32573437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
    Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
    BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
    López-Vicario C; Checa A; Urdangarin A; Aguilar F; Alcaraz-Quiles J; Caraceni P; Amorós A; Pavesi M; Gómez-Cabrero D; Trebicka J; Oettl K; Moreau R; Planell N; Arroyo V; Wheelock CE; Clària J
    J Hepatol; 2020 Oct; 73(4):817-828. PubMed ID: 32294533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.
    Ito A; Fujimura M; Niizuma K; Kanoke A; Sakata H; Morita-Fujimura Y; Kikuchi A; Kure S; Tominaga T
    Brain Res; 2015 Jan; 1594():310-20. PubMed ID: 25446450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of circulating SDF-1α and CD34+ CXCR4+ cells in patients with moyamoya disease.
    Ni G; Liu W; Huang X; Zhu S; Yue X; Chen Z; Chen M; Liu X; Xu G
    Eur J Neurol; 2011 Nov; 18(11):1304-9. PubMed ID: 21435112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing serum lipidomic characteristics and potential lipid biomarkers in patients with POEMS syndrome.
    Zhao H; Gao XM; Cao XX; Zhang L; Zhou DB; Li J
    J Cell Mol Med; 2021 May; 25(9):4307-4315. PubMed ID: 33779058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.